Essent Biologics™, a nonprofit biotechnology company providing low passaged primary cells, origin tissue, scaffolds and data to advance regenerative medicine research, today announced the appointment of Derek Mathers as Head of Business Development.
| CENTENNIAL, Colo., Feb. 16, 2021 /PRNewswire/ -- Essent Biologics™, a nonprofit biotechnology company providing low passaged primary cells, origin tissue, scaffolds and data to advance regenerative medicine research, today announced the appointment of Derek Mathers as Head of Business Development.
Prior to his role with Essent, Derek served as Director, Strategic Accounts for Advanced Solutions Life Sciences (ASLS), driving revenue through global 3D bioprinting partnerships with leading life science companies. Before ASLS, Derek led global sales at Worrell, where he consulted with leading healthcare companies to design, test and manufacture complex medical devices. While at Worrell, Derek also taught night classes as an adjunct professor of 3D Printing at the University of Minnesota (UMN). “We are thrilled to welcome Derek to our team,” said Corey Stone, Executive Director, Essent Biologics. “His knowledge and expertise will help drive Essent’s growth, as we continue to set a new standard in the field of regenerative medicine.” Derek earned his Bachelor of Science in Entrepreneurial Management and Digital Marketing from UMN’s Carlson School of Management and holds certificates in Tissue Engineering from Rice University, Cardiac Physiology and Anatomy from UMN, and Design for Additive Manufacturing from GE Additive. “Essent has a unique opportunity to provide human-derived biomaterials for the next generation of regenerative therapies,” said Derek Mathers, Head of Business Development. “I am humbled and grateful to join this talented team and look forward to contributing to our mission.” About Essent Biologics Media Contact
SOURCE Essent Biologics |
View original content to download multimedia: